Overview

Evaluation of the Efficacy and Safety of Diclofenac HPBCD 75mg/ml in Treatment of Pain Following Dental Surgery

Status:
Completed
Trial end date:
2010-05-01
Target enrollment:
Participant gender:
Summary
The present study is aimed at demonstrating the therapeutic equivalence of diclofenac HPBCD 75mg/1ml s.c. with the marketed reference product, Voltarol® 75mg/3ml i.m. in the treatment of acute moderate-to-severe pain after dental impaction surgery.
Phase:
Phase 3
Details
Lead Sponsor:
IBSA Institut Biochimique SA
Treatments:
Diclofenac